{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T16:01:19Z","timestamp":1782230479640,"version":"3.54.5"},"reference-count":65,"publisher":"Stanford University Press","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,26]],"date-time":"2021-05-26T00:00:00Z","timestamp":1621987200000},"content-version":"vor","delay-in-days":55,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Mass Spectrometry and Advances in the Clinical Lab"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.jmsacl.2021.05.002","type":"journal-article","created":{"date-parts":[[2021,5,29]],"date-time":"2021-05-29T02:59:53Z","timestamp":1622257193000},"page":"11-24","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Metabolomic and lipidomic characterization of an X-chromosome deletion disorder in neural progenitor cells by UHPLC-HRMS"],"prefix":"10.21627","volume":"20","author":[{"given":"Hoda Safari","family":"Yazd","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa Y.","family":"Rubio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Casey A.","family":"Chamberlain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard A.","family":"Yost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy J.","family":"Garrett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4811","reference":[{"issue":"4","key":"10.1016\/j.jmsacl.2021.05.002_b0005","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.ajhg.2012.02.018","article-title":"Fragile X and X-linked intellectual disability: four decades of discovery","volume":"90","author":"Lubs","year":"2012","journal-title":"Am. J. Hum. Genet."},{"issue":"4","key":"10.1016\/j.jmsacl.2021.05.002_b0010","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/ddrr.81","article-title":"X-linked intellectual disability: unique vulnerability of the male genome","volume":"15","author":"Stevenson","year":"2009","journal-title":"Dev. Disabil. Res. Rev."},{"issue":"11","key":"10.1016\/j.jmsacl.2021.05.002_b0015","doi-asserted-by":"crossref","first-page":"5498","DOI":"10.1210\/jcem.86.11.8058","article-title":"Turner syndrome and Xp deletions: clinical and molecular studies in 47 patients","volume":"86","author":"Ogata","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"10.1016\/j.jmsacl.2021.05.002_b0020","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1097\/00004703-200112000-00008","article-title":"The behavioral phenotype in fragile X: symptoms of autism in very young children with fragile X syndrome, idiopathic autism, and other developmental disorders","volume":"22","author":"Rogers","year":"2001","journal-title":"J. Dev. Behav. Pediatr."},{"issue":"1","key":"10.1016\/j.jmsacl.2021.05.002_b0025","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/mas.20108","article-title":"Mass spectrometry-based metabolomics","volume":"26","author":"Dettmer","year":"2007","journal-title":"Mass Spectrom. Rev."},{"issue":"4","key":"10.1016\/j.jmsacl.2021.05.002_b0030","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.trac.2004.11.021","article-title":"Metabolomics: current analytical platforms and methodologies","volume":"24","author":"Dunn","year":"2005","journal-title":"Trac-Trend Anal. Chem."},{"issue":"7","key":"10.1016\/j.jmsacl.2021.05.002_b0035","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/nrd1776","article-title":"The emerging field of lipidomics","volume":"4","author":"Wenk","year":"2005","journal-title":"Nat. Rev. Drug Discov."},{"issue":"7181","key":"10.1016\/j.jmsacl.2021.05.002_b0040","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/nature06802","article-title":"The search for new cardiovascular biomarkers","volume":"451","author":"Gerszten","year":"2008","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.jmsacl.2021.05.002_b0045","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/nrm.2016.25","article-title":"Metabolomics: beyond biomarkers and towards mechanisms","volume":"17","author":"Johnson","year":"2016","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.jmsacl.2021.05.002_b0050","doi-asserted-by":"crossref","DOI":"10.1186\/2040-2392-6-1","article-title":"Antipurinergic therapy corrects the autism-like features in the Fragile X (Fmr1 knockout) mouse model","volume":"6","author":"Naviaux","year":"2015","journal-title":"Mol. Autism"},{"issue":"12","key":"10.1016\/j.jmsacl.2021.05.002_b0055","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1101\/gr.116764.110","article-title":"A metabolomic and systems biology perspective on the brain of the Fragile X syndrome mouse model","volume":"21","author":"Davidovic","year":"2011","journal-title":"Genome Res."},{"key":"10.1016\/j.jmsacl.2021.05.002_b0060","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2019.00647","article-title":"Untargeted metabolomics for autism spectrum disorders: current status and future directions","volume":"10","author":"Glinton","year":"2019","journal-title":"Front. Psychiatry"},{"issue":"3","key":"10.1016\/j.jmsacl.2021.05.002_b0065","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9030664","article-title":"Metabolic fingerprint of Turner syndrome","volume":"9","author":"Bugajska","year":"2020","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.jmsacl.2021.05.002_b0070","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3389\/fnsyn.2018.00015","article-title":"Modeling neurological diseases with human brain organoids","volume":"10","author":"Wang","year":"2018","journal-title":"Front. Synaptic Neurosci."},{"issue":"5","key":"10.1016\/j.jmsacl.2021.05.002_b0075","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/j.neuro.2012.08.016","article-title":"Effect of low-dose thalidomide on dopaminergic neuronal differentiation of human neural progenitor cells: A combined study of metabolomics and morphological analysis","volume":"33","author":"Qin","year":"2012","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.jmsacl.2021.05.002_b0080","doi-asserted-by":"crossref","DOI":"10.1089\/cell.2020.0012","article-title":"Generation of induced pluripotent stem cells from a female patient with a Xq27.3-q28 deletion to establish disease models and identify therapies","author":"Watanabe","year":"2020","journal-title":"Cell Reprogram"},{"issue":"1","key":"10.1016\/j.jmsacl.2021.05.002_b0085","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0021-9258(18)64849-5","article-title":"A simple method for the isolation and purification of total lipids from animal tissues","volume":"226","author":"Folch","year":"1957","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.jmsacl.2021.05.002_b0090","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1007\/s13361-017-1608-0","article-title":"Expanding lipidome coverage using LC-MS\/MS data-dependent acquisition with automated exclusion list generation","volume":"28","author":"Koelmel","year":"2017","journal-title":"J. Am. Soc. Mass Spectr."},{"key":"10.1016\/j.jmsacl.2021.05.002_b0095","doi-asserted-by":"crossref","unstructured":"L. He, J. Diedrich, Y.Y. Chu, J.R. Yates 3rd, Extracting accurate precursor information for tandem mass spectra by RawConverter. Anal. Chem. (2015), 87 (22), 11361-7.","DOI":"10.1021\/acs.analchem.5b02721"},{"key":"10.1016\/j.jmsacl.2021.05.002_b0100","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1186\/1471-2105-11-395","article-title":"MZmine 2: modular framework for processing, visualizing, and analyzing mass spectrometry-based molecular profile data","volume":"11","author":"Pluskal","year":"2010","journal-title":"BMC Bioinf."},{"issue":"3","key":"10.1016\/j.jmsacl.2021.05.002_b0105","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s11306-007-0082-2","article-title":"Proposed minimum reporting standards for chemical analysis Chemical Analysis Working Group (CAWG) Metabolomics Standards Initiative (MSI)","volume":"3","author":"Sumner","year":"2007","journal-title":"Metabolomics"},{"key":"10.1016\/j.jmsacl.2021.05.002_b0110","doi-asserted-by":"crossref","DOI":"10.1186\/s12859-017-1744-3","article-title":"LipidMatch: an automated workflow for rule-based lipid identification using untargeted high-resolution tandem mass spectrometry data","volume":"18","author":"Koelmel","year":"2017","journal-title":"BMC Bioinf."},{"issue":"W1","key":"10.1016\/j.jmsacl.2021.05.002_b0115","doi-asserted-by":"crossref","first-page":"W486","DOI":"10.1093\/nar\/gky310","article-title":"MetaboAnalyst 4.0: towards more transparent and integrative metabolomics analysis","volume":"46","author":"Chong","year":"2018","journal-title":"Nucleic Acids Res."},{"issue":"2","key":"10.1016\/j.jmsacl.2021.05.002_b0120","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1109\/MCSE.2011.36","article-title":"Python for scientists and engineers","volume":"13","author":"Millman","year":"2011","journal-title":"Comput. Sci. Eng."},{"issue":"6","key":"10.1016\/j.jmsacl.2021.05.002_b0125","doi-asserted-by":"crossref","DOI":"10.1093\/gigascience\/giz061","article-title":"LION\/web: a web-based ontology enrichment tool for lipidomic data analysis","volume":"8","author":"Molenaar","year":"2019","journal-title":"GigaScience"},{"issue":"Database issue","key":"10.1016\/j.jmsacl.2021.05.002_b0130","doi-asserted-by":"crossref","first-page":"D521","DOI":"10.1093\/nar\/gkl923","article-title":"HMDB: the Human Metabolome Database","volume":"35","author":"Wishart","year":"2007","journal-title":"Nucleic Acids Res."},{"issue":"Database issue","key":"10.1016\/j.jmsacl.2021.05.002_b0135","doi-asserted-by":"crossref","first-page":"D603","DOI":"10.1093\/nar\/gkn810","article-title":"HMDB: a knowledgebase for the human metabolome","volume":"37","author":"Wishart","year":"2009","journal-title":"Nucleic Acids Res."},{"issue":"Database issue","key":"10.1016\/j.jmsacl.2021.05.002_b0140","first-page":"D801","article-title":"HMDB 3.0\u2013The Human Metabolome Database in 2013","volume":"41","author":"Wishart","year":"2013","journal-title":"Nucleic Acids Res."},{"issue":"D1","key":"10.1016\/j.jmsacl.2021.05.002_b0145","doi-asserted-by":"crossref","first-page":"D608","DOI":"10.1093\/nar\/gkx1089","article-title":"HMDB 4.0: the human metabolome database for 2018","volume":"46","author":"Wishart","year":"2018","journal-title":"Nucleic Acids Res."},{"issue":"D1","key":"10.1016\/j.jmsacl.2021.05.002_b0150","doi-asserted-by":"crossref","first-page":"D1102","DOI":"10.1093\/nar\/gky1033","article-title":"PubChem 2019 update: improved access to chemical data","volume":"47","author":"Kim","year":"2019","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.jmsacl.2021.05.002_b0155","first-page":"48","article-title":"The Kyoto encyclopedia of genes and genomes\u2013KEGG","volume":"17","author":"Wixon","year":"2000","journal-title":"Yeast"},{"issue":"11","key":"10.1016\/j.jmsacl.2021.05.002_b0160","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1002\/pro.3715","article-title":"Toward understanding the origin and evolution of cellular organisms","volume":"28","author":"Kanehisa","year":"2019","journal-title":"Protein Sci."},{"key":"10.1016\/j.jmsacl.2021.05.002_b0165","article-title":"KEGG: integrating viruses and cellular organisms","author":"Kanehisa","year":"2020","journal-title":"Nucleic Acids Res."},{"issue":"4","key":"10.1016\/j.jmsacl.2021.05.002_b0170","doi-asserted-by":"crossref","DOI":"10.3390\/metabo9040072","article-title":"CFM-ID 3.0: Significantly Improved ESI-MS\/MS Prediction and Compound Identification","volume":"9","author":"Djoumbou-Feunang","year":"2019","journal-title":"Metabolites"},{"issue":"19","key":"10.1016\/j.jmsacl.2021.05.002_b0175","doi-asserted-by":"crossref","first-page":"10397","DOI":"10.1021\/acs.analchem.7b02380","article-title":"Systems-level annotation of a metabolomics data set reduces 25 000 features to fewer than 1000 unique metabolites","volume":"89","author":"Mahieu","year":"2017","journal-title":"Anal. Chem."},{"issue":"5","key":"10.1016\/j.jmsacl.2021.05.002_b0180","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.cmet.2006.03.007","article-title":"The ratio of phosphatidylcholine to phosphatidylethanolamine influences membrane integrity and steatohepatitis","volume":"3","author":"Li","year":"2006","journal-title":"Cell Metab."},{"issue":"33","key":"10.1016\/j.jmsacl.2021.05.002_b0185","doi-asserted-by":"crossref","first-page":"25382","DOI":"10.1074\/jbc.M110.139477","article-title":"Phosphatidylcholine biosynthesis during neuronal differentiation and its role in cell fate determination","volume":"285","author":"Marcucci","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.jmsacl.2021.05.002_b0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0009-3084(00)00128-6","article-title":"Glycerophospholipids in brain: their metabolism, incorporation into membranes, functions, and involvement in neurological disorders","volume":"106","author":"Farooqui","year":"2000","journal-title":"Chem. Phys. Lipids"},{"issue":"2","key":"10.1016\/j.jmsacl.2021.05.002_b0195","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.ymgme.2004.09.015","article-title":"Elongation of very long-chain fatty acids is enhanced in X-linked adrenoleukodystrophy","volume":"84","author":"Kemp","year":"2005","journal-title":"Mol. Genet. Metab."},{"issue":"9","key":"10.1016\/j.jmsacl.2021.05.002_b0200","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1016\/j.bbamem.2017.04.006","article-title":"The critical role of phosphatidylcholine and phosphatidylethanolamine metabolism in health and disease","volume":"1859","author":"van der Veen","year":"2017","journal-title":"Biochim. Biophys. Acta Biomembr."},{"issue":"18","key":"10.1016\/j.jmsacl.2021.05.002_b0205","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1002\/1873-3468.12788","article-title":"From peroxisomal disorders to common neurodegenerative diseases - the role of ether phospholipids in the nervous system","volume":"591","author":"Dorninger","year":"2017","journal-title":"FEBS Lett."},{"issue":"1\u20132","key":"10.1016\/j.jmsacl.2021.05.002_b0210","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0006-8993(00)02205-8","article-title":"Phospholipid composition and levels are altered in Down syndrome brain","volume":"867","author":"Murphy","year":"2000","journal-title":"Brain Res."},{"issue":"2","key":"10.1016\/j.jmsacl.2021.05.002_b0215","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/j.1471-4159.2010.06614.x","article-title":"Altered brain phospholipid and acylcarnitine profiles in propionic acid infused rodents: further development of a potential model of autism spectrum disorders","volume":"113","author":"Thomas","year":"2010","journal-title":"J. Neurochem."},{"issue":"4","key":"10.1016\/j.jmsacl.2021.05.002_b0220","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1111\/j.1471-4159.2008.05513.x","article-title":"Plasmalogen deficiency in cerebral adrenoleukodystrophy and its modulation by lovastatin","volume":"106","author":"Khan","year":"2008","journal-title":"J. Neurochem."},{"issue":"3","key":"10.1016\/j.jmsacl.2021.05.002_b0225","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0151020","article-title":"Plasmalogen augmentation reverses striatal dopamine loss in MPTP mice","volume":"11","author":"Miville-Godbout","year":"2016","journal-title":"PLoS ONE"},{"issue":"10","key":"10.1016\/j.jmsacl.2021.05.002_b0230","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1097\/NEN.0b013e31826be03c","article-title":"Evidence for premature lipid raft aging in APP\/PS1 double-transgenic mice, a model of familial Alzheimer disease","volume":"71","author":"Fabelo","year":"2012","journal-title":"J. Neuropath. Exp. Neur."},{"key":"10.1016\/j.jmsacl.2021.05.002_b0235","doi-asserted-by":"crossref","DOI":"10.1186\/1476-511X-12-68","article-title":"Lipidomic analysis of brain tissues and plasma in a mouse model expressing mutated human amyloid precursor protein\/tau for Alzheimer's disease","volume":"12","author":"Tajima","year":"2013","journal-title":"Lipids Health Dis."},{"issue":"Pt 3","key":"10.1016\/j.jmsacl.2021.05.002_b0240","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1042\/bj3230807","article-title":"Delayed oxidative degradation of polyunsaturated diacyl phospholipids in the presence of plasmalogen phospholipids in vitro","volume":"323","author":"Reiss","year":"1997","journal-title":"Biochem. J."},{"issue":"4","key":"10.1016\/j.jmsacl.2021.05.002_b0245","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1083\/jcb.201604003","article-title":"Membrane curvature in cell biology: An integration of molecular mechanisms","volume":"214","author":"Jarsch","year":"2016","journal-title":"J. Cell Biol."},{"issue":"6","key":"10.1016\/j.jmsacl.2021.05.002_b0250","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1242\/jcs.114454","article-title":"Membrane curvature at a glance","volume":"128","author":"McMahon","year":"2015","journal-title":"J. Cell Sci."},{"issue":"Suppl 1","key":"10.1016\/j.jmsacl.2021.05.002_b0255","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1038\/sj.ejcn.1601810","article-title":"Role of long-chain polyunsaturated fatty acids in infant nutrition","volume":"57","author":"Gil","year":"2003","journal-title":"Eur. J. Clin. Nutr."},{"key":"10.1016\/j.jmsacl.2021.05.002_b0260","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2019.00533","article-title":"A more comprehensive approach to the neuroprotective potential of long-chain polyunsaturated fatty acids in preterm infants is needed-should we consider maternal diet and the n-6:n-3 fatty acid ratio?","volume":"7","author":"Klevebro","year":"2020","journal-title":"Front. Pediatr."},{"issue":"1\u20132","key":"10.1016\/j.jmsacl.2021.05.002_b0265","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1054\/plef.2000.0198","article-title":"The role of long-chain polyunsaturated fatty acids in infant cognitive development","volume":"63","author":"Willatts","year":"2000","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"issue":"4","key":"10.1016\/j.jmsacl.2021.05.002_b0270","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1017\/S1740925X11000093","article-title":"Roles of glutamine in neurotransmission","volume":"6","author":"Albrecht","year":"2010","journal-title":"Neuron Glia Biol."},{"issue":"1","key":"10.1016\/j.jmsacl.2021.05.002_b0275","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1866-1955-5-20","article-title":"Aberrant basal ganglia metabolism in fragile X syndrome: a magnetic resonance spectroscopy study","volume":"5","author":"Bruno","year":"2013","journal-title":"J. Neurodev. Disord."},{"issue":"4","key":"10.1016\/j.jmsacl.2021.05.002_b0280","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s40265-016-0542-y","article-title":"Pharmacotherapy for Fragile X Syndrome: progress to date","volume":"76","author":"Davenport","year":"2016","journal-title":"Drugs"},{"key":"10.1016\/j.jmsacl.2021.05.002_b0285","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.2741\/4636","article-title":"Choline, the brain and neurodegeneration: insights from epigenetics","volume":"23","author":"Bekdash","year":"2018","journal-title":"Front. Biosci. (Landmark Ed.)"},{"issue":"1\u20132","key":"10.1016\/j.jmsacl.2021.05.002_b0290","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1023\/A:1007054601256","article-title":"Phosphatidylcholine metabolism in human endothelial cells: modulation by phosphocholine","volume":"207","author":"Wong","year":"2000","journal-title":"Mol. Cell. Biochem."},{"issue":"1","key":"10.1016\/j.jmsacl.2021.05.002_b0295","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1186\/s12974-019-1659-1","article-title":"The pentose phosphate pathway regulates chronic neuroinflammation and dopaminergic neurodegeneration","volume":"16","author":"Tu","year":"2019","journal-title":"J. Neuroinflammation"},{"issue":"1","key":"10.1016\/j.jmsacl.2021.05.002_b0300","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003012","article-title":"Dysregulation of multiple metabolic networks related to brain transmethylation and polyamine pathways in Alzheimer disease: A targeted metabolomic and transcriptomic study","volume":"17","author":"Mahajan","year":"2020","journal-title":"PLoS Med."},{"issue":"3","key":"10.1016\/j.jmsacl.2021.05.002_b0305","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0119452","article-title":"Untargeted metabolomic analysis of human plasma indicates differentially affected polyamine and L-arginine metabolism in mild cognitive impairment subjects converting to Alzheimer's disease","volume":"10","author":"Graham","year":"2015","journal-title":"PLoS ONE"},{"issue":"1","key":"10.1016\/j.jmsacl.2021.05.002_b0310","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1023\/A:1022466714361","article-title":"Effect of caffeine on metabolism of L-arginine in the brain","volume":"244","author":"Nikolic","year":"2003","journal-title":"Mol. Cell. Biochem."},{"issue":"2","key":"10.1016\/j.jmsacl.2021.05.002_b0315","doi-asserted-by":"crossref","first-page":"137","DOI":"10.2174\/157488909788453004","article-title":"L-arginine signalling potential in the brain: the peripheral gets central","volume":"4","author":"Lameu","year":"2009","journal-title":"Recent Pat. CNS Drug Discov."},{"key":"10.1016\/j.jmsacl.2021.05.002_b0320","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2016.144","article-title":"Altered brain arginine metabolism in schizophrenia","volume":"6","author":"Liu","year":"2016","journal-title":"Transl. Psychiat."},{"issue":"6","key":"10.1016\/j.jmsacl.2021.05.002_b0325","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/j.neuron.2014.12.010","article-title":"Antisense proline-arginine RAN dipeptides linked to C9ORF72-ALS\/FTD form toxic nuclear aggregates that initiate in vitro and in vivo neuronal death","volume":"84","author":"Wen","year":"2014","journal-title":"Neuron"}],"container-title":["Journal of Mass Spectrometry and Advances in the Clinical Lab"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667145X21000092?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667145X21000092?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T07:22:23Z","timestamp":1767770543000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667145X21000092"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":65,"alternative-id":["S2667145X21000092"],"URL":"https:\/\/doi.org\/10.1016\/j.jmsacl.2021.05.002","relation":{},"ISSN":["2667-145X"],"issn-type":[{"value":"2667-145X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolomic and lipidomic characterization of an X-chromosome deletion disorder in neural progenitor cells by UHPLC-HRMS","name":"articletitle","label":"Article Title"},{"value":"Journal of Mass Spectrometry and Advances in the Clinical Lab","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmsacl.2021.05.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 THE AUTHORS. Publishing services by ELSEVIER B.V. on behalf of MSACL.","name":"copyright","label":"Copyright"}]}}